SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    H.M. Tlatoa-Ramírez, H.L. Ocaña-Servín, M.A. Fierro-González, M.A. Mondragón-Chimal, J. Bermeo-Méndez, Colangiopancreatografía retrógrada endoscópica en pancreatitis biliar aguda. ¿Herramienta diagnóstica o terapéutica? Revisión sistemática de la literatura 2008-2013, Medicina e Investigación, 2015, 3, 1, 3

    CrossRef

  2. 2
    Ge Yu, Shuang Li, Rong Wan, Xingpeng Wang, Guoyong Hu, Nafamostat Mesilate for Prevention of Post-ERCP Pancreatitis, Pancreas, 2015, 44, 4, 561

    CrossRef

  3. 3
    Vikesh K Singh, Robert A Moran, Elham Afghani, Enrique de-Madaria, Treating acute pancreatitis – what’s new?, Expert Review of Gastroenterology & Hepatology, 2015, 1

    CrossRef

  4. 4
    Robert A. Moran, Venkata S. Akshintala, Vikesh K. Singh, Post-endoscopic retrograde cholangiopancreatography pancreatitis: Risk stratification and appropriate patient selection, Techniques in Gastrointestinal Endoscopy, 2014, 16, 4, 156

    CrossRef

  5. 5
    Efstratios I. Koutroumpakis, Georgios I. Papachristou, Post–endoscopic retrograde cholangiopancreatography pancreatitis: Overview and pathophysiology, Techniques in Gastrointestinal Endoscopy, 2014, 16, 4, 150

    CrossRef

  6. 6
    Jiro Ohuchida, Kazuo Chijiiwa, Naoya Imamura, Motoaki Nagano, Masahide Hiyoshi, Randomized Controlled Trial for Efficacy of Nafamostat Mesilate in Preventing Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis, Pancreas, 2014, 1

    CrossRef

  7. 7
    Peter B. Cotton, Mohammad Yaghoobi, Adverse events,